MA20316A1 - Compose antibiotique,procede pour le preparer et compositions les contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions les contenant

Info

Publication number
MA20316A1
MA20316A1 MA20540A MA20540A MA20316A1 MA 20316 A1 MA20316 A1 MA 20316A1 MA 20540 A MA20540 A MA 20540A MA 20540 A MA20540 A MA 20540A MA 20316 A1 MA20316 A1 MA 20316A1
Authority
MA
Morocco
Prior art keywords
same
preparing
compositions containing
antibiotic compound
antibiotic
Prior art date
Application number
MA20540A
Other languages
English (en)
Inventor
Veikko Marttila Esko
Antero Uotila Jakko
Lauri Antero Marvola Marti
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MA20316A1 publication Critical patent/MA20316A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
MA20540A 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant MA20316A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
MA20316A1 true MA20316A1 (fr) 1985-10-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20540A MA20316A1 (fr) 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant

Country Status (38)

Country Link
US (1) US4599326A (fr)
JP (1) JPS60158197A (fr)
KR (1) KR900006237B1 (fr)
AT (1) AT386414B (fr)
AU (1) AU565688B2 (fr)
BE (1) BE901411A (fr)
BG (1) BG43189A3 (fr)
CA (1) CA1224461A (fr)
CH (1) CH666275A5 (fr)
CS (1) CS247191B2 (fr)
CY (1) CY1462A (fr)
DE (1) DE3500179A1 (fr)
DK (1) DK149776C (fr)
ES (1) ES8605818A1 (fr)
FI (1) FI77249C (fr)
FR (1) FR2557878B1 (fr)
GB (1) GB2152502B (fr)
HK (1) HK11590A (fr)
HU (1) HU196221B (fr)
IE (1) IE57967B1 (fr)
IL (1) IL73885A (fr)
IS (1) IS2968A7 (fr)
IT (1) IT1184304B (fr)
KE (1) KE3841A (fr)
LU (1) LU85721A1 (fr)
MA (1) MA20316A1 (fr)
MX (1) MX156277A (fr)
NL (1) NL8403979A (fr)
NO (1) NO160263C (fr)
NZ (1) NZ210606A (fr)
PH (1) PH22471A (fr)
PL (1) PL144349B1 (fr)
PT (1) PT79777B (fr)
RO (1) RO91262B (fr)
SE (1) SE461854B (fr)
SU (1) SU1410866A3 (fr)
YU (1) YU44485B (fr)
ZA (1) ZA8410143B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1594467A4 (fr) * 2002-07-05 2008-10-22 Collegium Pharmaceutical Inc Compositions pharmaceutiques d'opioides et d'autres medicaments empechants les utilisations abusives
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
HUE037643T2 (hu) 2004-06-12 2018-09-28 Collegium Pharmaceutical Inc Visszaélésre nem alkalmas gyógyszerkészítmények
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (fr) 2004-08-25 2006-03-09 The Uab Research Foundation Substances ameliorant l'absorption destinees a l'administration de medicaments
EP2158898A1 (fr) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilisation de compositions alkylglycosidiques et procédé correspondant
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP3566711A1 (fr) 2011-05-18 2019-11-13 Eumederis Pharmaceuticals, Inc. Agents pharmaceutiques peptidiques améliorés
EP4047023A1 (fr) 2012-11-20 2022-08-24 Eumederis Pharmaceuticals, Inc. Produits pharmaceutiques de peptides améliorés
EP3653649A1 (fr) 2012-11-20 2020-05-20 Mederis Diabetes, LLC Produits pharmaceutiques peptidiques améliorés pour la résistance à l'insuline
WO2014140699A1 (fr) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd Nouveau procédé de libération d'érythromycine et préparation de ses sels
IL285613B1 (en) 2014-05-28 2024-07-01 Mederis Diabetes Llc Improved peptide drugs for insulin resistance
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
MX2019013735A (es) 2017-05-19 2020-01-15 Lunella Biotech Inc Antimitoscinas: inhibidores especificos de la biogenesis mitocondrial para erradicar celulas madre cancerosas.
EP3717015A4 (fr) 2017-12-01 2021-07-28 Lunella Biotech, Inc. Repurposcins : inhibiteurs cibles de biogenèse mitochondriale pour éradiquer les cellules souches cancéreuses
ES2935684T3 (es) 2018-02-06 2023-03-09 Aegis Therapeutics Llc Formulaciones de epinefrina intranasales y métodos para el tratamiento de enfermedades
WO2019157099A1 (fr) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Formulations d'épinéphrine intranasale et méthodes de traitement d'une maladie
CN113453690A (zh) * 2018-12-17 2021-09-28 卢内拉生物技术有限公司 用于抗衰老的三联疗法
US20220040316A1 (en) * 2018-12-17 2022-02-10 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
NO850007L (no) 1985-07-08
DK149776C (da) 1987-04-21
ES8605818A1 (es) 1986-04-01
HUT37628A (en) 1986-01-23
NZ210606A (en) 1987-08-31
RO91262A (fr) 1987-06-30
SE461854B (sv) 1990-04-02
FR2557878A1 (fr) 1985-07-12
AU565688B2 (en) 1987-09-24
HK11590A (en) 1990-02-23
BG43189A3 (en) 1988-04-15
NL8403979A (nl) 1985-08-01
IL73885A0 (en) 1985-03-31
KR900006237B1 (ko) 1990-08-27
JPH029040B2 (fr) 1990-02-28
NO160263B (no) 1988-12-19
RO91262B (ro) 1987-07-01
IE57967B1 (en) 1993-06-02
IT8519012A0 (it) 1985-01-04
GB2152502B (en) 1987-10-07
JPS60158197A (ja) 1985-08-19
SU1410866A3 (ru) 1988-07-15
ZA8410143B (en) 1985-08-28
PH22471A (en) 1988-09-12
CH666275A5 (de) 1988-07-15
KE3841A (en) 1989-04-07
KR850005452A (ko) 1985-08-26
IT1184304B (it) 1987-10-28
DK149776B (da) 1986-09-29
FI850023L (fi) 1985-07-07
CA1224461A (fr) 1987-07-21
DE3500179C2 (fr) 1989-08-24
YU2085A (en) 1987-12-31
ATA985A (de) 1988-01-15
GB2152502A (en) 1985-08-07
YU44485B (en) 1990-08-31
AT386414B (de) 1988-08-25
ES539349A0 (es) 1986-04-01
DK5884D0 (da) 1984-01-06
AU3705984A (en) 1985-07-11
PL144349B1 (en) 1988-05-31
FI850023A0 (fi) 1985-01-03
FI77249C (fi) 1989-02-10
SE8406671D0 (sv) 1984-12-28
PT79777B (en) 1986-10-21
GB8432368D0 (en) 1985-02-06
SE8406671L (sv) 1985-07-07
US4599326A (en) 1986-07-08
LU85721A1 (fr) 1985-07-24
FI77249B (fi) 1988-10-31
DK5884A (da) 1985-07-07
DE3500179A1 (de) 1985-07-18
CS247191B2 (en) 1986-12-18
BE901411A (fr) 1985-04-16
HU196221B (en) 1988-10-28
CY1462A (en) 1989-07-21
PT79777A (en) 1985-01-01
IE850022L (en) 1985-07-06
IS2968A7 (is) 1985-04-03
NO160263C (no) 1989-03-29
IL73885A (en) 1988-10-31
MX156277A (es) 1988-08-04
FR2557878B1 (fr) 1988-01-15
PL251457A1 (en) 1985-11-05

Similar Documents

Publication Publication Date Title
MA20316A1 (fr) Compose antibiotique,procede pour le preparer et compositions les contenant
FR2577551B1 (fr) Derives de benzoyl uree, procede pour les preparer, et compositions antitumorales les contenant
PH21995A (en) Antibiotic compounds, their composition and process for the preparation of said compound
FR2569691B1 (fr) Derives de benzimidazole, procede pour les preparer et agents anti-ulcereux les contenant
AU585561B2 (en) New peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same
BE893010A (fr) Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques les contenant
FI851269L (fi) Anlaeggning foer kontinuerlig pressning av en pressgodsmatta i samband med framstaellningen av spaonplattor, fiberplattor och liknande.
IL64345A (en) Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
FR2565227B1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
GB8429910D0 (en) Biochemical process & composition
FR2521135B1 (fr) Composes polyanioniques, procede pour les preparer et compositions les contenant
EP0159708A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same
FR2552433B1 (fr) Nouveaux derives de 1,3,4-thiadiazole, procede pour leur preparation et leur utilisation comme agents anti-ulcere
DK206482A (da) Vaekstmediesammensaetning
FR2519989B1 (fr) Monohydrates de steroides, formules en contenant et procede pour les preparer
PT77428A (fr) Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
FR2573762B1 (fr) Derives 4-hydroxyphenylthioalkyliques substitues, compositions les contenant et leur procede d'emploi
EP0069154A4 (fr) Nouveaux composes de thiazole, procede de preparation, et composition medicinale en contenant.
PH16945A (en) Substituted triphenyl thiazole compounds,their pharmaceutical compositions and their use
FR2590260B1 (fr) Nitro-anthracycline, aglycone correspondante, procedes pour les preparer, composition pharmaceutique correspondante
FR2510129B1 (fr) Compose d'addition et son procede de preparation
HUT38537A (en) Process for producing pharmaceutical compositions containing peneme or carbapeneme antibiotics
DE3264578D1 (en) Thio-substituted-1,3,5-triazine-diamines and -triamines useful as prevulcanization inhibitors
MA20115A1 (fr) (Delta3-thiadiazoline-1,2,3 ylidene-5)-urees, procede pour les preparer et produits regulateurs de croissance et defoliants contenant de telles urees.